Details
Stereochemistry | ACHIRAL |
Molecular Formula | C6H6O24P6.6Ca |
Molecular Weight | 888.408 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 6 / 6 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[Ca++].[Ca++].[Ca++].[Ca++].[Ca++].[Ca++].[O-]P([O-])(=O)O[C@@H]1[C@H](OP([O-])([O-])=O)[C@H](OP([O-])([O-])=O)[C@@H](OP([O-])([O-])=O)[C@H](OP([O-])([O-])=O)[C@H]1OP([O-])([O-])=O
InChI
InChIKey=WPEXVRDUEAJUGY-BQYPOXACSA-B
InChI=1S/C6H18O24P6.6Ca/c7-31(8,9)25-1-2(26-32(10,11)12)4(28-34(16,17)18)6(30-36(22,23)24)5(29-35(19,20)21)3(1)27-33(13,14)15;;;;;;/h1-6H,(H2,7,8,9)(H2,10,11,12)(H2,13,14,15)(H2,16,17,18)(H2,19,20,21)(H2,22,23,24);;;;;;/q;6*+2/p-12/t1-,2-,3-,4+,5-,6-;;;;;;
CALCIUM PHYTATE is a calcium salt of phytic acid (also known as myo-inositol hexakisphosphate (IP6), inositol polyphosphate), which is a strong chelator (complexing agent) of important minerals such as calcium, iron. In nature, it functions as storage for phosphorus in plants, especially in the hulls of nuts and seeds. Phytic acid (IP6) for a long period was considered an antinutritional factor. However, in vitro and in vivo studies have demonstrated its beneficial effects in the prevention and treatment of several pathological conditions and cancer. It also exhibits protective action in Parkinson's disease and this is correlated with its anti-inflammatory effect, which may be associated with suppression of pathways that involved in NF-κB and p-ERK. In addition was discovered, that phytic acid might provide a viable treatment option for Alzheimer's disease.
CNS Activity
Sources: https://www.ncbi.nlm.nih.gov/pubmed/11502236
Curator's Comment: Known to be CNS penetrant in rat. Human data not available
Originator
Sources: http://www.stri.si.edu/sites/inositol_conference/program/PDFs/monday_morning/Mullaney.pdf
Curator's Comment: 1903
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: iron Sources: https://www.ncbi.nlm.nih.gov/pubmed/8772254 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | Unknown Approved UseUnknown |
|||
Primary | Unknown Approved UseUnknown |
|||
Primary | Unknown Approved UseUnknown |
|||
Preventing | Unknown Approved UseUnknown |
PubMed
Title | Date | PubMed |
---|---|---|
Inositol hexakisphosphate binds to clathrin assembly protein 3 (AP-3/AP180) and inhibits clathrin cage assembly in vitro. | 1995 Jan 6 |
|
A phospholipase C-dependent inositol polyphosphate kinase pathway required for efficient messenger RNA export. | 1999 Jul 2 |
|
Phytate levels in diverse rat tissues: influence of dietary phytate. | 2001 Aug |
|
Assessing the omnipotence of inositol hexakisphosphate. | 2001 Mar |
|
Inositol hexa phosphoric acid (phytic acid), a nutraceuticals, attenuates iron-induced oxidative stress and alleviates liver injury in iron overloaded mice. | 2017 Mar |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/20930278
in mice (alzheimer's pathology): 2% phytic acid in drinking water for 70 days
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/12834920
It was examined the antioxidant effect of phytic acid on iron (II)-enhanced hydroxyl radical (*OH) generation induced by 1-methyl-4-phenylpyridinium ion (MPP(+)) in the extracellular fluid of rat striatum. Phytic acid (100 microM) did not significantly decrease the levels of MPP(+)-induced *OH formation trapped as 2,3-DHBA. To confirm the generation of *OH by the Fenton-type reaction, iron (II) was infused through a microdialysis probe. Introduction of iron (II) (10 microM) enhanced MPP(+) induced *OH generation. However, phytic acid significantly suppressed iron (II)-enhanced *OH formation after MPP(+) treatment (n=6, P<0.05). These results suggest that the antiradical effect of phytic acid occurs by chelating iron required for the MPP(+)-enhanced *OH generation via the Fenton-type reaction.
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
DSLD |
3413 (Number of products:2)
Created by
admin on Fri Dec 15 15:24:35 GMT 2023 , Edited by admin on Fri Dec 15 15:24:35 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
7776-28-5
Created by
admin on Fri Dec 15 15:24:35 GMT 2023 , Edited by admin on Fri Dec 15 15:24:35 GMT 2023
|
PRIMARY | |||
|
L1WK0T5S7Z
Created by
admin on Fri Dec 15 15:24:35 GMT 2023 , Edited by admin on Fri Dec 15 15:24:35 GMT 2023
|
PRIMARY | |||
|
100000076569
Created by
admin on Fri Dec 15 15:24:35 GMT 2023 , Edited by admin on Fri Dec 15 15:24:35 GMT 2023
|
PRIMARY | |||
|
962
Created by
admin on Fri Dec 15 15:24:35 GMT 2023 , Edited by admin on Fri Dec 15 15:24:35 GMT 2023
|
PRIMARY | |||
|
24495
Created by
admin on Fri Dec 15 15:24:35 GMT 2023 , Edited by admin on Fri Dec 15 15:24:35 GMT 2023
|
PRIMARY | |||
|
231-897-9
Created by
admin on Fri Dec 15 15:24:35 GMT 2023 , Edited by admin on Fri Dec 15 15:24:35 GMT 2023
|
PRIMARY | |||
|
DTXSID40998952
Created by
admin on Fri Dec 15 15:24:35 GMT 2023 , Edited by admin on Fri Dec 15 15:24:35 GMT 2023
|
PRIMARY |
PARENT (SALT/SOLVATE)
SUBSTANCE RECORD